NATALIE GEORGE: Open Payments
NPI 1114298510 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$125,802 in 399 payments from 22 companies in 2025. Trend: 2023 $132,876 · 2024 $137,078 · 2025 $125,802
Speaker / faculty: $77,967Honoraria: $18,900Consulting: $13,276Travel & lodging: $8,701Food & beverage: $6,714Education: $244
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 73 | $29,285 |
| Lilly USA, LLC | 41 | $22,378 |
| ABBVIE INC. | 64 | $19,902 |
| Incyte Corporation | 42 | $13,567 |
| GENZYME CORPORATION | 19 | $11,682 |
| Regeneron Healthcare Solutions, Inc. | 28 | $11,072 |
| Janssen Biotech, Inc. | 33 | $10,482 |
| UCB, Inc. | 14 | $5,230 |
| E.R. Squibb & Sons, L.L.C. | 4 | $682 |
| Novartis Pharmaceuticals Corporation | 17 | $410 |
Products named: VTAMA, DUPIXENT, EBGLYSS, Opzelura, RINVOQ, TREMFYA, SKYRIZI, Bimzelx.
Industry payments across AL — which companies pay providers there.
